AI Summary
The article discusses the development of an injectable tissue adhesive microgel composite that contains an antifibrotic drug for treating vocal fold scarring. This novel approach aims to improve the efficacy of current treatments for vocal fold scarring by delivering the drug directly to the affected area using a minimally invasive injection. The use of tissue adhesive microgels enhances the drug's retention at the target site, leading to better treatment outcomes. This research has the potential to significantly benefit patients with vocal fold scarring and may pave the way for innovative treatment options in the field of laryngology.